Lv2
140 积分 2024-07-05 加入
Heart failure with preserved ejection fraction epidemiology, pathophysiology, diagnosis and treatment strategies
3天前
已完结
Diagnosing diastolic dysfunction and heart failure with preserved ejection fraction in patients with atrial fibrillation: a clinical challenge
3天前
已完结
Prognostic Models for Mortality and Morbidity in Heart Failure With Preserved Ejection Fraction
3天前
已完结
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
12天前
已完结
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
12天前
已完结
Laboratory and Metabolomic Fingerprint in Heart Failure with Preserved Ejection Fraction: From Clinical Classification to Biomarker Signature
1个月前
已完结
Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review
1个月前
已完结
Soluble ST2 in Heart Failure With Preserved Ejection Fraction
1个月前
已完结
The utility of growth differentiation factor-15, galectin-3, and sST2 as biomarkers for the diagnosis of heart failure with preserved ejection fraction and compared to heart failure with reduced ejection fraction: a systematic review
1个月前
已完结
Galectin-3 and HFpEF: Clarifying an Emerging Relationship
1个月前
已完结
皖公网安备34019202002308
